Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This appears to be a minor backend/CMS patch with no changes to study content or patient-facing information.
    Difference
    0.0%
    Check dated 2026-09-03T13:53:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    NIH grant/contract funding lines for 2019 and 2023 were added to the study record to reflect the funding sources.
    Difference
    0.1%
    Check dated 2026-08-27T11:11:13.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page as a new version identifier. The Plain Language Summary and Revision: v3.6.4 have been removed, indicating a small administrative update to the study documentation.
    Difference
    0.1%
    Check dated 2026-08-13T01:57:35.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows updated and removed date entries (e.g., 2026-07-30, 2026-08-21, 2026-07-28, 2026-07) indicating maintenance timestamps rather than changes to the study content.
    Difference
    0.2%
    Check dated 2026-08-06T00:19:21.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.3 to v3.6.4 in the history, signaling a new build or update of the page. This reflects deployment/maintenance activity rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-22T16:40:46.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3 on the study entry, representing a minor metadata update to the ClinicalTrials.gov record. It does not alter study details, eligibility, locations, or results.
    Difference
    0.0%
    Check dated 2026-07-01T09:31:35.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.